| Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418 IV Maucher, M Ruehl, SBM Kretschmer, B Hofmann, B Kuehn, J Fettel, ... Biochemical Pharmacology 125, 55-74, 2017 | 25 | 2017 |
| Impact of structural relaxation on mechanical properties of amorphous polymers K Flügel, R Hennig, M Thommes European Journal of Pharmaceutics and Biopharmaceutics 154, 214-221, 2020 | 19 | 2020 |
| Impact of incorporated drugs on material properties of amorphous solid dispersions K Flügel, K Schmidt, L Mareczek, M Gäbe, R Hennig, M Thommes European Journal of Pharmaceutics and Biopharmaceutics 159, 88-98, 2021 | 7 | 2021 |
| Determination of the structural relaxation enthalpy using a mathematical approach K Flügel, R Hennig, M Thommes Journal of Pharmaceutical Sciences 108 (11), 3675-3683, 2019 | 3 | 2019 |
| Genesis, mechanism, and avoidance of cosmetic coating defects–An industrial case study K Flügel, R Wiedey, C Riehl, I Kaminski, M Riehl International Journal of Pharmaceutics 655, 124008, 2024 | | 2024 |
| Influence of Structural Relaxation and the Incorporated Drug on Material Properties of Amorphous Solid Dispersions K Flügel Technische Universität Dortmund, 2022 | | 2022 |
| Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418 M Piesche, IV Maucher, M Rühl, S Kretschmer, B Hofmann, B Kühn, ... | | 2017 |
